<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml">
   <article xmlns="" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
      <head>
         <style type="text/css"> 		 
            	    table {background : #ffffdd;}
            		 	tr {background : #ddddff; padding : 1px;}
            			
         </style>
         <span class="citation_publisher">Hindawi Publishing Corporation</span>
         <h2 class="citation-title">Acute Lymphoblastic Leukemia Arising in CALR Mutated Essential Thrombocythemia</h2>
         <span class="doi">10.1155/2016/6545861</span>
         <div class="contrib-group">contrib: 
            	  CONT
            	  
            <span class="citation_author">Stephen E. Langabeer</span>
            <span class="citation_author_institution_ref">1</span>
            <span class="citation_author">Karl Haslam</span>
            <span class="citation_author_institution_ref">1</span>
            <span class="citation_author">David O'Brien</span>
            <span class="citation_author_institution_ref">2</span>
            <span class="citation_author">Johanna Kelly</span>
            <span class="citation_author_institution_ref">3</span>
            <span class="citation_author">Claire Andrews</span>
            <span class="citation_author_institution_ref">2</span>
            <span class="citation_author">Ciara Ryan</span>
            <span class="citation_author_institution_ref">4</span>
            <span class="citation_author">Richard Flavin</span>
            <span class="citation_author_institution_ref">4</span>
            <span class="citation_author">Patrick J. Hayden</span>
            <span class="citation_author_institution_ref">2</span>
            <span class="citation_author">Christopher L. Bacon</span>
            <span class="citation_author_institution_ref">2</span>
         </div>
         <span class="email">[slangabeer@stjames.ie]</span>
         <span class="conflict">[]</span>
         <span class="contribs">[]</span>
         <span class="citation_pubdate">[2016-1-21]</span>
         <span class="citation_copyright">[Copyright 2016: ]</span>
         <span class="citation_licence">[Licence This is an open access article distributed under the Creative Commons Attribution
            License, which permits unrestricted use, distribution, and reproduction in any medium,
            provided the original work is properly cited.]
         </span>
         <span class="citation_funding">[]</span>
         <span class="citation_pagecount">[]</span>
         <span class="citation_data">[]</span>
      </head>
      <div id="abstract" tag="abstract">
         <h2>Abstract</h2>
         <p>The development of acute lymphoblastic leukemia in an existing myeloproliferative
            neoplasm is rare with historical cases unable to differentiate between concomitant
            malignancies or leukemic transformation. Molecular studies of coexisting
            <i> JAK2</i> V617F-positive myeloproliferative neoplasms and mature B cell malignancies indicate
            distinct disease entities arising in myeloid and lymphoid committed hematopoietic
            progenitor cells, respectively. Mutations of
            <i> CALR</i> in essential thrombocythemia appear to be associated with a distinct phenotype and
            a lower risk of thrombosis yet their impact on disease progression is less well defined.
            The as yet undescribed scenario of pro-B cell acute lymphoblastic leukemia arising
            in
            <i> CALR</i> mutated essential thrombocythemia is presented. Intensive treatment for the leukemia
            allowed for expansion of the original
            <i> CALR</i> mutated clone. Whether
            <i> CALR</i> mutations in myeloproliferative neoplasms predispose to the acquisition of additional
            malignancies, particularly lymphoproliferative disorders, is not yet known.
         </p>
      </div>
      <div tagxxx="sec">
         <title>1. Introduction</title>
         <p>Essential thrombocythemia (ET), together with polycythemia vera (PV), and primary
            myelofibrosis (PMF) are subtypes of the clinically and pathologically related Philadelphia
            chromosome-negative myeloproliferative neoplasms (MPN). ET is characterized by a sustained
            peripheral blood thrombocytosis and elevated numbers of mature, large megakaryocytes
            in the bone marrow and clinically by episodes of hemorrhage and/or thrombosis [
            <span ref-type="bibr" rid="B1">
               <sup>
                  <a href="#B1">1</a>
               </sup>
            </span>]. Identification of an acquired, clonal mutation has become a fundamental aspect
            of ET diagnosis [
            <span ref-type="bibr" rid="B2">
               <sup>
                  <a href="#B2">2</a>
               </sup>
            </span>] with identification of mutations of
            <i> JAK2</i>,
            <i> MPL</i>, and
            <i> CALR</i> likely to be incorporated into the revised World Health Organization diagnostic criteria
            for this MPN [
            <span ref-type="bibr" rid="B3">
               <sup>
                  <a href="#B3">3</a>
               </sup>
            </span>].
         </p>
         <p>Although a relatively indolent disorder, there exists a potential for ET patients
            to transform to a myelofibrotic or leukemic phase. While most leukemic transformations
            in MPN resemble acute myeloid leukemia [
            <span ref-type="bibr" rid="B4">
               <sup>
                  <a href="#B4">4</a>
               </sup>
            </span>], transformations to, or coexistence of, an acute lymphoblastic leukemia (ALL) of
            either B cell or T cell phenotype are uncommon but have been documented in PV [
            <span ref-type="bibr" rid="B5">
               <sup>
                  <a href="#B5">5</a>
               </sup>
            </span>–
            <span ref-type="bibr" rid="B10">
               <sup>
                  <a href="#B10">10</a>
               </sup>
            </span>], ET [
            <span ref-type="bibr" rid="B11">
               <sup>
                  <a href="#B11">11</a>
               </sup>
            </span>–
            <span ref-type="bibr" rid="B14">
               <sup>
                  <a href="#B14">14</a>
               </sup>
            </span>], PMF [
            <span ref-type="bibr" rid="B15">
               <sup>
                  <a href="#B15">15</a>
               </sup>
            </span>–
            <span ref-type="bibr" rid="B17">
               <sup>
                  <a href="#B17">17</a>
               </sup>
            </span>], post-PV MF [
            <span ref-type="bibr" rid="B18">
               <sup>
                  <a href="#B18">18</a>
               </sup>
            </span>], and MPN unclassified [
            <span ref-type="bibr" rid="B19">
               <sup>
                  <a href="#B19">19</a>
               </sup>
            </span>] which usually become apparent following treatment with alkylating agents or radioactive
            phosphorus. Whether all these cases represent a true clonal evolution of the MPN or
            are the manifestation of two separate diseases remains unresolved in most historical
            instances. Clinical management of such cases is complex requiring consideration of
            both pathologies.
         </p>
         <p>From the initial report of
            <i> CALR</i> mutations in MPN, it has become increasingly evident that
            <i> CALR</i>-positive ET patients possess a different phenotype from their
            <i> JAK2</i> V617F-positive counterparts with a younger age, male predominance, higher platelet
            count, lower hemoglobin, lower leucocyte count, and, perhaps most clinically relevant,
            a lower risk of thrombosis [
            <span ref-type="bibr" rid="B20">
               <sup>
                  <a href="#B20">20</a>
               </sup>
            </span>–
            <span ref-type="bibr" rid="B25">
               <sup>
                  <a href="#B25">25</a>
               </sup>
            </span>]. However, the impact of
            <i> CALR</i> mutations on myelofibrotic and leukemic transformation is less well defined [
            <span ref-type="bibr" rid="B21">
               <sup>
                  <a href="#B21">21</a>
               </sup>
            </span>–
            <span ref-type="bibr" rid="B23">
               <sup>
                  <a href="#B23">23</a>
               </sup>
            </span>]. Furthermore, an increased risk of lymphoid neoplasms, particularly mature B cell
            malignancies such as chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphoma,
            has been reported in MPN patients compared to the general population [
            <span ref-type="bibr" rid="B26">
               <sup>
                  <a href="#B26">26</a>
               </sup>
            </span>, 
            <span ref-type="bibr" rid="B27">
               <sup>
                  <a href="#B27">27</a>
               </sup>
            </span>] suggesting a pathophysiological link between the two diseases. A specific genetic
            cause or microenvironmental, inflammatory interaction for this predisposition has
            yet to be identified. A case is described of a hitherto unreported development of
            ALL in a patient with
            <i> CALR</i> mutated ET.
         </p>
      </div>
      <div tagxxx="sec">
         <title>2. Case Report</title>
         <p>A 65-year-old female presented with an incidentally detected thrombocytosis in 2012.
            Initial hematological investigation showed a hemoglobin of 13.5 g/dL, white cell count
            of 6.2 × 10
            <sup>9</sup>/L, and platelets of 674 × 10
            <sup>9</sup>/L with platelet anisocytosis and giant platelets on the peripheral blood (PB) film.
            The bone marrow (BM) aspirate and biopsy were both slightly hypercellular with increased
            numbers of clustering megakaryocytes (
            <span ref-type="fig" rid="fig1">Figure 1(a)</span>) and no increase in reticulin fibrosis consistent with a diagnosis of ET. Cytogenetic
            analysis was not performed at this time. The
            <i> JAK2</i> V617F mutation was not detected by allele-specific PCR [
            <span ref-type="bibr" rid="B28">
               <sup>
                  <a href="#B28">28</a>
               </sup>
            </span>]. The patient was commenced on aspirin and hydroxyurea to bring the platelet count
            within normal range. Retrospective fragment length analysis for
            <i> CALR</i> mutations [
            <span ref-type="bibr" rid="B29">
               <sup>
                  <a href="#B29">29</a>
               </sup>
            </span>] on the archived, diagnostic, unselected, and PB DNA demonstrated the presence of
            a type 1 mutation (52-bp deletion, p.L367fs
            <sup>
               <i>∗</i>
            </sup>46) at an allele burden of 49% (
            <span ref-type="fig" rid="fig1">Figure 1(b)</span>).
         </p>
         <p>Three and a half years after ET diagnosis, the patient presented with left hip pain,
            hemoglobin of 12.3 g/dL, white cell count of 5.3 × 10
            <sup>9</sup>/L, platelets of 261 × 10
            <sup>9</sup>/L, and a lactate dehydrogenase of 1186 IU/L. Macrocytosis, nucleated red blood cells,
            myelocytes, and 2% blasts of lymphoid appearance were observed on the PB film. In
            the BM aspirate, blasts with a high N/C ratio with prominent cytoplasmic vacuolation
            and blebbing accounted for 53% of nucleated cells morphologically (
            <span ref-type="fig" rid="fig1">Figure 1(c)</span>) and were CD34+, CD19+, HLA DR+, CD20+, CD38+, TdT+, and CD10− by multicolor flow
            cytometry and CD34+, PAX5+, TdT+, CD10−, and MPO− by immunohistochemistry, consistent
            with a diagnosis of pro-B ALL. There was no evidence of increased reticulin fibrosis.
            Cytogenetic analysis demonstrated a near-triploid clone of 60~67, XXX, +X, +1, −3,
            −7, +8, −9, add(14)(p11), −15, −16, −17, +18, +18, +19, −20, and +21 [cp7]. The unselected
            BM
            <i> CALR</i> mutant allele burden at the time of ALL diagnosis was 51%. The patient commenced
            induction chemotherapy with dexamethasone, idarubicin, vincristine, and methotrexate
            attaining a morphological, cytogenetic, and immunophenotypic remission. Recovery from
            induction was associated with a rising platelet count peaking at 1163 × 10
            <sup>9</sup>/L and an unselected BM
            <i> CALR</i> mutant allele burden of 67%. Following a course of consolidation chemotherapy the
            patient remained in morphological, cytogenetic, and immunophenotypic remission, with
            increased megakaryocytes still evident on the BM biopsy (
            <span ref-type="fig" rid="fig1">Figure 1(d)</span>). The recovery platelet count peaked at 470 × 10
            <sup>9</sup>/L with an unselected BM
            <i> CALR</i> mutant allele burden of 72% (
            <span ref-type="fig" rid="fig1">Figure 1(e)</span>). The patient was unsuitable for allogeneic hematopoietic stem cell transplantation
            (AHSCT) and she remains on treatment for both ALL and ET.
         </p>
      </div>
      <div tagxxx="sec">
         <title>3. Discussion</title>
         <p>The development of ALL in patients with an existing MPN, whether concomitant or representing
            a true leukemic evolution, has been sporadically documented [
            <span ref-type="bibr" rid="B5">
               <sup>
                  <a href="#B5">5</a>
               </sup>
            </span>–
            <span ref-type="bibr" rid="B19">
               <sup>
                  <a href="#B19">19</a>
               </sup>
            </span>]. In the pre-
            <i>JAK2</i> V617F era, only cytogenetic evidence was available to support the existence of distinct
            entities [
            <span ref-type="bibr" rid="B30">
               <sup>
                  <a href="#B30">30</a>
               </sup>
            </span>]. However, cell sorting and mutational analysis of hematopoietic stem and progenitor
            cells in ET and PV cases with coexisting CLL have demonstrated the absence of the
            <i> JAK2</i> V617F and, in one previous case, a
            <i> CALR</i> mutation, in the lymphoid compartment [
            <span ref-type="bibr" rid="B31">
               <sup>
                  <a href="#B31">31</a>
               </sup>
            </span>–
            <span ref-type="bibr" rid="B34">
               <sup>
                  <a href="#B34">34</a>
               </sup>
            </span>]. Similar investigations in cases of ALL arising in MPN have distinguished separate
            clonal origins of the two hematopoietic malignancies [
            <span ref-type="bibr" rid="B35">
               <sup>
                  <a href="#B35">35</a>
               </sup>
            </span>, 
            <span ref-type="bibr" rid="B36">
               <sup>
                  <a href="#B36">36</a>
               </sup>
            </span>] therefore weakening the argument for lymphoblastic transformation. However, it remains
            possible that the ALL could be derived from a malignant subclone prior to the acquisition
            of the
            <i> CALR</i> mutation. Low numbers of circulating peripheral blood lymphoblasts prohibited such
            a selection procedure in this case.
         </p>
         <p>Recent evidence suggests that the two most common
            <i> CALR</i> mutation types might influence the MPN phenotype and disease course: type 1 mutations
            appear to be associated with PMF phenotype whereas type 2 mutations (a 5-bp insertion,
            p.K385fs
            <sup>
               <i>∗</i>
            </sup>47) are more commonly observed in ET [
            <span ref-type="bibr" rid="B37">
               <sup>
                  <a href="#B37">37</a>
               </sup>
            </span>–
            <span ref-type="bibr" rid="B39">
               <sup>
                  <a href="#B39">39</a>
               </sup>
            </span>]. Type 1
            <i> CALR</i> mutations in ET, as evident in the patient described herein, are also associated
            with a higher risk of myelofibrotic transformation although the biological mechanism(s)
            for this have yet to be clarified: impaired calcium signalling and calcium binding
            activity to mutant CALR protein have been preferentially demonstrated in type 1
            <i> CALR</i> mutated MPN [
            <span ref-type="bibr" rid="B39">
               <sup>
                  <a href="#B39">39</a>
               </sup>
            </span>]. At present there is no evidence of equivalence of mutated
            <i> CALR</i> allele burden between peripheral blood and bone marrow; however, of particular note
            is the mutated
            <i> CALR</i> allele burden after ALL treatment. Mutant
            <i> CALR</i> allele burdens greater than 50% are rare in ET and PMF at diagnosis suggesting the
            majority of mutations are heterozygous. The relatively high mutant
            <i> CALR</i> allele burdens after ALL treatment might represent loss of heterozygosity in at least
            some mutant clones, analogous to that observed in the progression of
            <i> JAK2</i> V617F-positive PV [
            <span ref-type="bibr" rid="B40">
               <sup>
                  <a href="#B40">40</a>
               </sup>
            </span>].
         </p>
         <p>Hydroxyurea is commonly used for the long term treatment of MPN and is well tolerated
            in the majority of patients. Some early debate suggested that hydroxyurea might contribute
            to or hastens leukemic transformation; however it was unsure whether transformation
            was part of the natural history in such instances [
            <span ref-type="bibr" rid="B41">
               <sup>
                  <a href="#B41">41</a>
               </sup>
            </span>]. Several large studies have subsequently confirmed that hydroxyurea is not associated
            with myelofibrotic or leukemic transformation in MPN [
            <span ref-type="bibr" rid="B42">
               <sup>
                  <a href="#B42">42</a>
               </sup>
            </span>–
            <span ref-type="bibr" rid="B45">
               <sup>
                  <a href="#B45">45</a>
               </sup>
            </span>]. Some studies have reported an increased risk of other cancers, including hematological
            malignancies, in MPN with myelosuppressive treatment speculated to be a potential
            cause. Epidemiological evidence of this increased cancer incidence is supported by
            noting malignancies prior to MPN diagnosis thus eliminating the influence of MPN related
            treatment [
            <span ref-type="bibr" rid="B46">
               <sup>
                  <a href="#B46">46</a>
               </sup>
            </span>]. The cooccurrence of MPN and solid tumors may be attributed to the presence of a
            predisposing
            <i> TERT</i> polymorphism [
            <span ref-type="bibr" rid="B47">
               <sup>
                  <a href="#B47">47</a>
               </sup>
            </span>]. Another possible common denominator in MPN occurring in conjunction with other
            malignancies is chronic inflammation, able to potentiate each other's existence and
            progression [
            <span ref-type="bibr" rid="B48">
               <sup>
                  <a href="#B48">48</a>
               </sup>
            </span>].
         </p>
         <p>While the coexistence of MPN and mature B cell lymphoproliferative disorders has been
            documented, cases of MPN and ALL are extremely scarce. We describe, to the best of
            our knowledge, the clinical course of the first case of pro-B ALL arising in a patient
            with
            <i> CALR</i> mutated ET. The persistence of the
            <i> CALR</i> mutated clone following treatment for ALL suggests that long term eradication of
            both diseases would be only achievable with AHSCT.
         </p>
      </div>
      <back>
         <div tagxxx="sec">
            <title>Conflict of Interests</title>
            <p>The authors declare that there is no conflict of interests regarding the publication
               of this paper.
            </p>
         </div>
         <div tag="ref-list">
            <ul>
               <li tag="ref">
                  <a name="B1"></a>
                  <label>1</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Thiele</span>
                           <span tagx="given-names">J.</span>
                        </name>
                        <name>
                           <span tagx="surname">Kvasnicka</span>
                           <span tagx="given-names">H. M.</span>
                        </name>
                        <name>
                           <span tagx="surname">Orazi</span>
                           <span tagx="given-names">A.</span>
                        </name>
                        <name>
                           <span tagx="surname">Tefferi</span>
                           <span tagx="given-names">A.</span>
                        </name>
                        <name>
                           <span tagx="surname">Gisslinger</span>
                           <span tagx="given-names">H.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Essential thrombocythaemia</span>
                     <span tagx="source">
                        <i>WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues</i>
                     </span>
                     <span tagx="year">2008</span>
                     <span class="publisher-loc'">[Lyon, France]</span>
                     <span class="publisher-name'">[International Agency for Research on Cancer]</span>
                     <span tagx="fpage">48</span>
                     <span tagx="lpage">50</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B2"></a>
                  <label>2</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Langabeer</span>
                           <span tagx="given-names">S. E.</span>
                        </name>
                        <name>
                           <span tagx="surname">Andrikovics</span>
                           <span tagx="given-names">H.</span>
                        </name>
                        <name>
                           <span tagx="surname">Asp</span>
                           <span tagx="given-names">J.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Molecular diagnostics of myeloproliferative neoplasms</span>
                     <span tagx="source">
                        <i>European Journal of Haematology</i>
                     </span>
                     <span tagx="year">2015</span>
                     <span tagx="volume">95</span>
                     <div tagxxx="issue">4</div>
                     <span tagx="fpage">270</span>
                     <span tagx="lpage">279</span>
                     <span class="pub-id'">[10.1111/ejh.12578]</span>
                     <span class="pub-id'">[25951317]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B3"></a>
                  <label>3</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Barbui</span>
                           <span tagx="given-names">T.</span>
                        </name>
                        <name>
                           <span tagx="surname">Thiele</span>
                           <span tagx="given-names">J.</span>
                        </name>
                        <name>
                           <span tagx="surname">Vannucchi</span>
                           <span tagx="given-names">A. M.</span>
                        </name>
                        <name>
                           <span tagx="surname">Tefferi</span>
                           <span tagx="given-names">A.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia
                        vera, essential thrombocythemia and primary myelofibrosis
                     </span>
                     <span tagx="source">
                        <i>Blood Cancer Journal</i>
                     </span>
                     <span tagx="year">2015</span>
                     <span tagx="volume">5</span>
                     <div tagxxx="issue">8, article e337</div>
                     <span class="pub-id'">[10.1038/bcj.2015.64]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B4"></a>
                  <label>4</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Czader</span>
                           <span tagx="given-names">M.</span>
                        </name>
                        <name>
                           <span tagx="surname">Orazi</span>
                           <span tagx="given-names">A.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Acute myeloid leukemia and other types of disease progression in myeloproliferative
                        neoplasms
                     </span>
                     <span tagx="source">
                        <i>American Journal of Clinical Pathology</i>
                     </span>
                     <span tagx="year">2015</span>
                     <span tagx="volume">144</span>
                     <div tagxxx="issue">2</div>
                     <span tagx="fpage">188</span>
                     <span tagx="lpage">206</span>
                     <span class="pub-id'">[10.1309/ajcpzqk40jozzzcc]</span>
                     <span class="pub-id'">[26185305]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B5"></a>
                  <label>5</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Hoffman</span>
                           <span tagx="given-names">R.</span>
                        </name>
                        <name>
                           <span tagx="surname">Estren</span>
                           <span tagx="given-names">S.</span>
                        </name>
                        <name>
                           <span tagx="surname">Kopel</span>
                           <span tagx="given-names">S.</span>
                        </name>
                        <name>
                           <span tagx="surname">Marks</span>
                           <span tagx="given-names">S. M.</span>
                        </name>
                        <name>
                           <span tagx="surname">McCaffrey</span>
                           <span tagx="given-names">R. P.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Lymphoblastic-like leukemic transformation of polycythemia vera</span>
                     <span tagx="source">
                        <i>Annals of Internal Medicine</i>
                     </span>
                     <span tagx="year">1978</span>
                     <span tagx="volume">89</span>
                     <div tagxxx="issue">1</div>
                     <span tagx="fpage">p. 71</span>
                     <span class="pub-id'">[10.7326/0003-4819-89-1-71]</span>
                     <span class="pub-id'">[2-s2.0-0017841024]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B6"></a>
                  <label>6</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Braich</span>
                           <span tagx="given-names">T. A.</span>
                        </name>
                        <name>
                           <span tagx="surname">Grogan</span>
                           <span tagx="given-names">T. M.</span>
                        </name>
                        <name>
                           <span tagx="surname">Hicks</span>
                           <span tagx="given-names">M. J.</span>
                        </name>
                        <name>
                           <span tagx="surname">Greenberg</span>
                           <span tagx="given-names">B. R.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Terminal lymphoblastic transformation in polycythemia vera</span>
                     <span tagx="source">
                        <i>The American Journal of Medicine</i>
                     </span>
                     <span tagx="year">1986</span>
                     <span tagx="volume">80</span>
                     <div tagxxx="issue">2</div>
                     <span tagx="fpage">304</span>
                     <span tagx="lpage">306</span>
                     <span class="pub-id'">[10.1016/0002-9343(86)90029-X]</span>
                     <span class="pub-id'">[2-s2.0-0022617692]</span>
                     <span class="pub-id'">[3456200]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B7"></a>
                  <label>7</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Aitchison</span>
                           <span tagx="given-names">R.</span>
                        </name>
                        <name>
                           <span tagx="surname">Black</span>
                           <span tagx="given-names">A. J.</span>
                        </name>
                        <name>
                           <span tagx="surname">Greaves</span>
                           <span tagx="given-names">M. F.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Polycythaemia rubra vera transforming to acute lymphoblastic leukaemia</span>
                     <span tagx="source">
                        <i>Clinical and Laboratory Haematology</i>
                     </span>
                     <span tagx="year">1987</span>
                     <span tagx="volume">9</span>
                     <div tagxxx="issue">2</div>
                     <span tagx="fpage">201</span>
                     <span tagx="lpage">204</span>
                     <span class="pub-id'">[10.1111/j.1365-2257.1987.tb01402.x]</span>
                     <span class="pub-id'">[2-s2.0-0023222318]</span>
                     <span class="pub-id'">[3476236]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B8"></a>
                  <label>8</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Neilson</span>
                           <span tagx="given-names">J. R.</span>
                        </name>
                        <name>
                           <span tagx="surname">Patton</span>
                           <span tagx="given-names">W. N.</span>
                        </name>
                        <name>
                           <span tagx="surname">Williams</span>
                           <span tagx="given-names">M. D.</span>
                        </name>
                        <name>
                           <span tagx="surname">Mayne</span>
                           <span tagx="given-names">E. E.</span>
                        </name>
                        <name>
                           <span tagx="surname">Boughton</span>
                           <span tagx="given-names">B. J.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Polycythaemia rubra vera transforming to acute lymphoblastic leukaemia with a common
                        immunophenotype
                     </span>
                     <span tagx="source">
                        <i>Journal of Clinical Pathology</i>
                     </span>
                     <span tagx="year">1994</span>
                     <span tagx="volume">47</span>
                     <div tagxxx="issue">5</div>
                     <span tagx="fpage">471</span>
                     <span tagx="lpage">472</span>
                     <span class="pub-id'">[10.1136/jcp.47.5.471]</span>
                     <span class="pub-id'">[2-s2.0-0028303834]</span>
                     <span class="pub-id'">[8027406]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B9"></a>
                  <label>9</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Arai</span>
                           <span tagx="given-names">Y.</span>
                        </name>
                        <name>
                           <span tagx="surname">Masuda</span>
                           <span tagx="given-names">M.</span>
                        </name>
                        <name>
                           <span tagx="surname">Okamura</span>
                           <span tagx="given-names">T.</span>
                        </name>
                        <name>
                           <span tagx="surname">Wada</span>
                           <span tagx="given-names">M.</span>
                        </name>
                        <name>
                           <span tagx="surname">Motoji</span>
                           <span tagx="given-names">T.</span>
                        </name>
                        <name>
                           <span tagx="surname">Mizoguchi</span>
                           <span tagx="given-names">H.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Polycythemia vera progressing to acute lymphoblastic leukemia after 13 years</span>
                     <span tagx="source">
                        <i>Rinshō Ketsueki</i>
                     </span>
                     <span tagx="year">1996</span>
                     <span tagx="volume">37</span>
                     <div tagxxx="issue">12</div>
                     <span tagx="fpage">1405</span>
                     <span tagx="lpage">1409</span>
                     <span class="pub-id'">[2-s2.0-0030338505]</span>
                     <span class="pub-id'">[8997130]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B10"></a>
                  <label>10</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Camós</span>
                           <span tagx="given-names">M.</span>
                        </name>
                        <name>
                           <span tagx="surname">Cervantes</span>
                           <span tagx="given-names">F.</span>
                        </name>
                        <name>
                           <span tagx="surname">Montoto</span>
                           <span tagx="given-names">S.</span>
                        </name>
                        <name>
                           <span tagx="surname">Hernández-Boluda</span>
                           <span tagx="given-names">J. C.</span>
                        </name>
                        <name>
                           <span tagx="surname">Villamor</span>
                           <span tagx="given-names">N.</span>
                        </name>
                        <name>
                           <span tagx="surname">Montserrat</span>
                           <span tagx="given-names">E.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Acute lymphoid leukemia following polycythemia vera</span>
                     <span tagx="source">
                        <i>Leukemia &amp; Lymphoma</i>
                     </span>
                     <span tagx="year">1999</span>
                     <span tagx="volume">32</span>
                     <div tagxxx="issue">3-4</div>
                     <span tagx="fpage">395</span>
                     <span tagx="lpage">398</span>
                     <span class="pub-id'">[2-s2.0-0033051292]</span>
                     <span class="pub-id'">[10037041]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B11"></a>
                  <label>11</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">O'Hea</span>
                           <span tagx="given-names">A. M.</span>
                        </name>
                        <name>
                           <span tagx="surname">Erber</span>
                           <span tagx="given-names">W.</span>
                        </name>
                        <name>
                           <span tagx="surname">O'Connor</span>
                           <span tagx="given-names">N. T. J.</span>
                        </name>
                        <name>
                           <span tagx="surname">Bunch</span>
                           <span tagx="given-names">C.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Acute transformation of essential thrombocythaemia: report of two cases</span>
                     <span tagx="source">
                        <i>Journal of Clinical Pathology</i>
                     </span>
                     <span tagx="year">1986</span>
                     <span tagx="volume">39</span>
                     <div tagxxx="issue">12</div>
                     <span tagx="fpage">1296</span>
                     <span tagx="lpage">1298</span>
                     <span class="pub-id'">[10.1136/jcp.39.12.1296]</span>
                     <span class="pub-id'">[2-s2.0-0022861193]</span>
                     <span class="pub-id'">[3468122]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B12"></a>
                  <label>12</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Murphy</span>
                           <span tagx="given-names">P. T.</span>
                        </name>
                        <name>
                           <span tagx="surname">Sivakumaran</span>
                           <span tagx="given-names">M.</span>
                        </name>
                        <name>
                           <span tagx="surname">van Rhee</span>
                           <span tagx="given-names">F.</span>
                        </name>
                        <name>
                           <span tagx="surname">Watmore</span>
                           <span tagx="given-names">A. E.</span>
                        </name>
                        <name>
                           <span tagx="surname">Mitchell</span>
                           <span tagx="given-names">V. E.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Acute lymphoblastic transformation of essential thrombocythaemia</span>
                     <span tagx="source">
                        <i>British Journal of Haematology</i>
                     </span>
                     <span tagx="year">1995</span>
                     <span tagx="volume">89</span>
                     <div tagxxx="issue">4</div>
                     <span tagx="fpage">921</span>
                     <span tagx="lpage">922</span>
                     <span class="pub-id'">[2-s2.0-0028910109]</span>
                     <span class="pub-id'">[7772536]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B13"></a>
                  <label>13</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Woronzoff-Dashkoff</span>
                           <span tagx="given-names">K. K.</span>
                        </name>
                        <name>
                           <span tagx="surname">Litz</span>
                           <span tagx="given-names">C. E.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Acute lymphoblastic leukemia in a case of essential thrombocythemia</span>
                     <span tagx="source">
                        <i>American Journal of Clinical Pathology</i>
                     </span>
                     <span tagx="year">1996</span>
                     <span tagx="volume">106</span>
                     <div tagxxx="issue">2</div>
                     <span tagx="fpage">206</span>
                     <span tagx="lpage">208</span>
                     <span class="pub-id'">[2-s2.0-0029847955]</span>
                     <span class="pub-id'">[8712175]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B14"></a>
                  <label>14</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Berkahn</span>
                           <span tagx="given-names">L. C.</span>
                        </name>
                        <name>
                           <span tagx="surname">Nelson</span>
                           <span tagx="given-names">J.</span>
                        </name>
                        <name>
                           <span tagx="surname">Ockelford</span>
                           <span tagx="given-names">P. A.</span>
                        </name>
                        <name>
                           <span tagx="surname">Browett</span>
                           <span tagx="given-names">P. J.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Transformation of essential thrombocythaemia to T cell acute lymphoblastic leukaemia</span>
                     <span tagx="source">
                        <i>Leukemia and Lymphoma</i>
                     </span>
                     <span tagx="year">1995</span>
                     <span tagx="volume">20</span>
                     <div tagxxx="issue">3-4</div>
                     <span tagx="fpage">347</span>
                     <span tagx="lpage">349</span>
                     <span class="pub-id'">[2-s2.0-0029589715]</span>
                     <span class="pub-id'">[8624479]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B15"></a>
                  <label>15</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Shaheen</span>
                           <span tagx="given-names">S. P.</span>
                           <div tagxxx="suffix">II</div>
                        </name>
                        <name>
                           <span tagx="surname">Talwalkar</span>
                           <span tagx="given-names">S. S.</span>
                        </name>
                        <name>
                           <span tagx="surname">Simons</span>
                           <span tagx="given-names">R.</span>
                        </name>
                        <name>
                           <span tagx="surname">Yam</span>
                           <span tagx="given-names">L.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Acute lymphoblastic leukemic transformation in a patient with chronic idiopathic myelofibrosis
                        and paroxysmal nocturnal hemoglobinuria
                     </span>
                     <span tagx="source">
                        <i>Archives of Pathology &amp; Laboratory Medicine</i>
                     </span>
                     <span tagx="year">2005</span>
                     <span tagx="volume">129</span>
                     <div tagxxx="issue">1</div>
                     <span tagx="fpage">96</span>
                     <span tagx="lpage">99</span>
                     <span class="pub-id'">[2-s2.0-11844276955]</span>
                     <span class="pub-id'">[15628917]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B16"></a>
                  <label>16</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Sever</span>
                           <span tagx="given-names">M.</span>
                        </name>
                        <name>
                           <span tagx="surname">Jorgensen</span>
                           <span tagx="given-names">J. L.</span>
                        </name>
                        <name>
                           <span tagx="surname">Gurevich</span>
                           <span tagx="given-names">I.</span>
                        </name>
                        <name>
                           <span tagx="surname">Pinheiro</span>
                           <span tagx="given-names">M.</span>
                        </name>
                        <name>
                           <span tagx="surname">Verstovsek</span>
                           <span tagx="given-names">S.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Primary myelofibrosis with concurrent precursor T-cell lymphoblastic lymphoma of the
                        spleen in a 26-year-old patient
                     </span>
                     <span tagx="source">
                        <i>Leukemia Research</i>
                     </span>
                     <span tagx="year">2009</span>
                     <span tagx="volume">33</span>
                     <div tagxxx="issue">11</div>
                     <span tagx="fpage">e186</span>
                     <span tagx="lpage">e188</span>
                     <span class="pub-id'">[10.1016/j.leukres.2009.05.005]</span>
                     <span class="pub-id'">[2-s2.0-68649100141]</span>
                     <span class="pub-id'">[19482354]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B17"></a>
                  <label>17</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Jurisic</span>
                           <span tagx="given-names">V.</span>
                        </name>
                        <name>
                           <span tagx="surname">Colovic</span>
                           <span tagx="given-names">N.</span>
                        </name>
                        <name>
                           <span tagx="surname">Terzic</span>
                           <span tagx="given-names">T.</span>
                        </name>
                        <name>
                           <span tagx="surname">Djordjevic</span>
                           <span tagx="given-names">V.</span>
                        </name>
                        <name>
                           <span tagx="surname">Colovic</span>
                           <span tagx="given-names">M.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Transformation of primary myelofibrosis with 20q- in Philadelphia-positive acute lymphoblastic
                        leukemia: case report and review of literature
                     </span>
                     <span tagx="source">
                        <i>Pathology Research and Practice</i>
                     </span>
                     <span tagx="year">2012</span>
                     <span tagx="volume">208</span>
                     <div tagxxx="issue">7</div>
                     <span tagx="fpage">420</span>
                     <span tagx="lpage">423</span>
                     <span class="pub-id'">[10.1016/j.prp.2012.04.007]</span>
                     <span class="pub-id'">[2-s2.0-84863815856]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B18"></a>
                  <label>18</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Ohanian</span>
                           <span tagx="given-names">M.</span>
                        </name>
                        <name>
                           <span tagx="surname">Leventaki</span>
                           <span tagx="given-names">V.</span>
                        </name>
                        <name>
                           <span tagx="surname">Verstovsek</span>
                           <span tagx="given-names">S.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Acute lymphoblastic leukemia arising in post-polycythemic myelofibrosis: a rare entity</span>
                     <span tagx="source">
                        <i>Leukemia and Lymphoma</i>
                     </span>
                     <span tagx="year">2012</span>
                     <span tagx="volume">53</span>
                     <div tagxxx="issue">9</div>
                     <span tagx="fpage">1839</span>
                     <span tagx="lpage">1841</span>
                     <span class="pub-id'">[10.3109/10428194.2012.663916]</span>
                     <span class="pub-id'">[2-s2.0-84865033356]</span>
                     <span class="pub-id'">[22303899]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B19"></a>
                  <label>19</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Bacher</span>
                           <span tagx="given-names">U.</span>
                        </name>
                        <name>
                           <span tagx="surname">Haferlach</span>
                           <span tagx="given-names">T.</span>
                        </name>
                        <name>
                           <span tagx="surname">Kern</span>
                           <span tagx="given-names">W.</span>
                        </name>
                        <name>
                           <span tagx="surname">Harich</span>
                           <span tagx="given-names">H.-D.</span>
                        </name>
                        <name>
                           <span tagx="surname">Schnittger</span>
                           <span tagx="given-names">S.</span>
                        </name>
                        <name>
                           <span tagx="surname">Haferlach</span>
                           <span tagx="given-names">C.</span>
                        </name>
                     </span>
                     <span tagx="article-title">A case of chronic myeloproliferative syndrome followed by precursor T-cell acute lymphoblastic
                        leukemia
                     </span>
                     <span tagx="source">
                        <i>Cancer Genetics &amp; Cytogenetics</i>
                     </span>
                     <span tagx="year">2007</span>
                     <span tagx="volume">175</span>
                     <div tagxxx="issue">1</div>
                     <span tagx="fpage">52</span>
                     <span tagx="lpage">56</span>
                     <span class="pub-id'">[10.1016/j.cancergencyto.2006.12.007]</span>
                     <span class="pub-id'">[2-s2.0-34247847812]</span>
                     <span class="pub-id'">[17498558]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B20"></a>
                  <label>20</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Klampfl</span>
                           <span tagx="given-names">T.</span>
                        </name>
                        <name>
                           <span tagx="surname">Gisslinger</span>
                           <span tagx="given-names">H.</span>
                        </name>
                        <name>
                           <span tagx="surname">Harutyunyan</span>
                           <span tagx="given-names">A. S.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Somatic mutations of calreticulin in myeloproliferative neoplasms</span>
                     <span tagx="source">
                        <i>The New England Journal of Medicine</i>
                     </span>
                     <span tagx="year">2013</span>
                     <span tagx="volume">369</span>
                     <div tagxxx="issue">25</div>
                     <span tagx="fpage">2379</span>
                     <span tagx="lpage">2390</span>
                     <span class="pub-id'">[24325356]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B21"></a>
                  <label>21</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Rumi</span>
                           <span tagx="given-names">E.</span>
                        </name>
                        <name>
                           <span tagx="surname">Pietra</span>
                           <span tagx="given-names">D.</span>
                        </name>
                        <name>
                           <span tagx="surname">Ferretti</span>
                           <span tagx="given-names">V.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially
                        different clinical course and outcomes
                     </span>
                     <span tagx="source">
                        <i>Blood</i>
                     </span>
                     <span tagx="year">2014</span>
                     <span tagx="volume">123</span>
                     <div tagxxx="issue">10</div>
                     <span tagx="fpage">1544</span>
                     <span tagx="lpage">1551</span>
                     <span class="pub-id'">[10.1182/blood-2013-11-539098]</span>
                     <span class="pub-id'">[2-s2.0-84897517940]</span>
                     <span class="pub-id'">[24366362]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B22"></a>
                  <label>22</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Rotunno</span>
                           <span tagx="given-names">G.</span>
                        </name>
                        <name>
                           <span tagx="surname">Mannarelli</span>
                           <span tagx="given-names">C.</span>
                        </name>
                        <name>
                           <span tagx="surname">Guglielmelli</span>
                           <span tagx="given-names">P.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Impact of calreticulin mutations on clinical and hematological phenotype and outcome
                        in essential thrombocythemia
                     </span>
                     <span tagx="source">
                        <i>Blood</i>
                     </span>
                     <span tagx="year">2014</span>
                     <span tagx="volume">123</span>
                     <div tagxxx="issue">10</div>
                     <span tagx="fpage">1552</span>
                     <span tagx="lpage">1555</span>
                     <span class="pub-id'">[10.1182/blood-2013-11-538983]</span>
                     <span class="pub-id'">[2-s2.0-84897568260]</span>
                     <span class="pub-id'">[24371211]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B23"></a>
                  <label>23</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Tefferi</span>
                           <span tagx="given-names">A.</span>
                        </name>
                        <name>
                           <span tagx="surname">Wassie</span>
                           <span tagx="given-names">E. A.</span>
                        </name>
                        <name>
                           <span tagx="surname">Lasho</span>
                           <span tagx="given-names">T. L.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Calreticulin mutations and long-term survival in essential thrombocythemia</span>
                     <span tagx="source">
                        <i>Leukemia</i>
                     </span>
                     <span tagx="year">2014</span>
                     <span tagx="volume">28</span>
                     <div tagxxx="issue">12</div>
                     <span tagx="fpage">2300</span>
                     <span tagx="lpage">2303</span>
                     <span class="pub-id'">[10.1038/leu.2014.148]</span>
                     <span class="pub-id'">[2-s2.0-84901383293]</span>
                     <span class="pub-id'">[24791854]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B24"></a>
                  <label>24</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Andrikovics</span>
                           <span tagx="given-names">H.</span>
                        </name>
                        <name>
                           <span tagx="surname">Krahling</span>
                           <span tagx="given-names">T.</span>
                        </name>
                        <name>
                           <span tagx="surname">Balassa</span>
                           <span tagx="given-names">K.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Distinct clinical characteristics of myeloproliferative neoplasms with calreticulin
                        mutations
                     </span>
                     <span tagx="source">
                        <i>Haematologica</i>
                     </span>
                     <span tagx="year">2014</span>
                     <span tagx="volume">99</span>
                     <div tagxxx="issue">7</div>
                     <span tagx="fpage">1184</span>
                     <span tagx="lpage">1190</span>
                     <span class="pub-id'">[10.3324/haematol.2014.107482]</span>
                     <span class="pub-id'">[2-s2.0-84903648668]</span>
                     <span class="pub-id'">[24895336]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B25"></a>
                  <label>25</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Trifa</span>
                           <span tagx="given-names">A. P.</span>
                        </name>
                        <name>
                           <span tagx="surname">Popp</span>
                           <span tagx="given-names">R. A.</span>
                        </name>
                        <name>
                           <span tagx="surname">Cucuianu</span>
                           <span tagx="given-names">A.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">CALR versus JAK2 mutated essential thrombocythaemia—a report on 141 patients</span>
                     <span tagx="source">
                        <i>British Journal of Haematology</i>
                     </span>
                     <span tagx="year">2015</span>
                     <span tagx="volume">168</span>
                     <div tagxxx="issue">1</div>
                     <span tagx="fpage">151</span>
                     <span tagx="lpage">153</span>
                     <span class="pub-id'">[10.1111/bjh.13076]</span>
                     <span class="pub-id'">[2-s2.0-84915747253]</span>
                     <span class="pub-id'">[25103987]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B26"></a>
                  <label>26</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Vannucchi</span>
                           <span tagx="given-names">A. M.</span>
                        </name>
                        <name>
                           <span tagx="surname">Masala</span>
                           <span tagx="given-names">G.</span>
                        </name>
                        <name>
                           <span tagx="surname">Antonioli</span>
                           <span tagx="given-names">E.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Increased risk of lymphoid neoplasms in patients with Philadelphia chromosome-negative
                        myeloproliferative neoplasms
                     </span>
                     <span tagx="source">
                        <i>Cancer Epidemiology Biomarkers and Prevention</i>
                     </span>
                     <span tagx="year">2009</span>
                     <span tagx="volume">18</span>
                     <div tagxxx="issue">7</div>
                     <span tagx="fpage">2068</span>
                     <span tagx="lpage">2073</span>
                     <span class="pub-id'">[10.1158/1055-9965.EPI-09-0353]</span>
                     <span class="pub-id'">[2-s2.0-67650439240]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B27"></a>
                  <label>27</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Miltiades</span>
                           <span tagx="given-names">P.</span>
                        </name>
                        <name>
                           <span tagx="surname">Lamprianidou</span>
                           <span tagx="given-names">E.</span>
                        </name>
                        <name>
                           <span tagx="surname">Kerzeli</span>
                           <span tagx="given-names">I. K.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Three-fold higher frequency of circulating chronic lymphocytic leukemia-like B-cell
                        clones in patients with Ph-myeloproliferative neoplasms
                     </span>
                     <span tagx="source">
                        <i>Leukemia Research</i>
                     </span>
                     <span tagx="year">2015</span>
                     <span tagx="volume">39</span>
                     <div tagxxx="issue">11</div>
                     <span tagx="fpage">1159</span>
                     <span tagx="lpage">1165</span>
                     <span class="pub-id'">[10.1016/j.leukres.2015.08.004]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B28"></a>
                  <label>28</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Baxter</span>
                           <span tagx="given-names">E. J.</span>
                        </name>
                        <name>
                           <span tagx="surname">Scott</span>
                           <span tagx="given-names">L. M.</span>
                        </name>
                        <name>
                           <span tagx="surname">Campbell</span>
                           <span tagx="given-names">P. J.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders</span>
                     <span tagx="source">
                        <i>The Lancet</i>
                     </span>
                     <span tagx="year">2005</span>
                     <span tagx="volume">365</span>
                     <div tagxxx="issue">9464</div>
                     <span tagx="fpage">1054</span>
                     <span tagx="lpage">1061</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B29"></a>
                  <label>29</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Haslam</span>
                           <span tagx="given-names">K.</span>
                        </name>
                        <name>
                           <span tagx="surname">Langabeer</span>
                           <span tagx="given-names">S. E.</span>
                        </name>
                        <name>
                           <span tagx="surname">Molloy</span>
                           <span tagx="given-names">K.</span>
                        </name>
                        <name>
                           <span tagx="surname">Mcmullin</span>
                           <span tagx="given-names">M. F.</span>
                        </name>
                        <name>
                           <span tagx="surname">Conneally</span>
                           <span tagx="given-names">E.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Assessment of CALR mutations in myelofibrosis patients, post-allogeneic stem cell
                        transplantation
                     </span>
                     <span tagx="source">
                        <i>British Journal of Haematology</i>
                     </span>
                     <span tagx="year">2014</span>
                     <span tagx="volume">166</span>
                     <div tagxxx="issue">5</div>
                     <span tagx="fpage">800</span>
                     <span tagx="lpage">802</span>
                     <span class="pub-id'">[10.1111/bjh.12904]</span>
                     <span class="pub-id'">[2-s2.0-84906050602]</span>
                     <span class="pub-id'">[24749731]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B30"></a>
                  <label>30</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Anastasi</span>
                           <span tagx="given-names">J.</span>
                        </name>
                        <name>
                           <span tagx="surname">Pettenati</span>
                           <span tagx="given-names">M. J.</span>
                        </name>
                        <name>
                           <span tagx="surname">Le Beau</span>
                           <span tagx="given-names">M. M.</span>
                        </name>
                        <name>
                           <span tagx="surname">Kwaan</span>
                           <span tagx="given-names">H. C.</span>
                        </name>
                        <name>
                           <span tagx="surname">Weil</span>
                           <span tagx="given-names">S. C.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Acute lymphoblastic leukemia in a patient with longstanding polycythemia vera: cytogenetic
                        analysis reveals two distinct abnormal clones
                     </span>
                     <span tagx="source">
                        <i>American Journal of Hematology</i>
                     </span>
                     <span tagx="year">1988</span>
                     <span tagx="volume">29</span>
                     <div tagxxx="issue">1</div>
                     <span tagx="fpage">33</span>
                     <span tagx="lpage">37</span>
                     <span class="pub-id'">[10.1002/ajh.2830290108]</span>
                     <span class="pub-id'">[2-s2.0-0023774814]</span>
                     <span class="pub-id'">[3177367]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B31"></a>
                  <label>31</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Henry</span>
                           <span tagx="given-names">L.</span>
                        </name>
                        <name>
                           <span tagx="surname">Carillo</span>
                           <span tagx="given-names">S.</span>
                        </name>
                        <name>
                           <span tagx="surname">Jourdan</span>
                           <span tagx="given-names">E.</span>
                        </name>
                        <name>
                           <span tagx="surname">Arnaud</span>
                           <span tagx="given-names">A.</span>
                        </name>
                        <name>
                           <span tagx="surname">Brun</span>
                           <span tagx="given-names">S.</span>
                        </name>
                        <name>
                           <span tagx="surname">Lavabre-Bertrand</span>
                           <span tagx="given-names">T.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Association of essential thrombocythemia and chronic lymphocytic leukemia: absence
                        of the V617F JAK2 mutation in the lymphoid compartment
                     </span>
                     <span tagx="source">
                        <i>American Journal of Hematology</i>
                     </span>
                     <span tagx="year">2007</span>
                     <span tagx="volume">82</span>
                     <div tagxxx="issue">6</div>
                     <span tagx="fpage">500</span>
                     <span tagx="lpage">501</span>
                     <span class="pub-id'">[10.1002/ajh.20870]</span>
                     <span class="pub-id'">[2-s2.0-34249796100]</span>
                     <span class="pub-id'">[17301972]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B32"></a>
                  <label>32</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Musolino</span>
                           <span tagx="given-names">C.</span>
                        </name>
                        <name>
                           <span tagx="surname">Allegra</span>
                           <span tagx="given-names">A.</span>
                        </name>
                        <name>
                           <span tagx="surname">Penna</span>
                           <span tagx="given-names">G.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Absence of the V617F JAK2 mutation in the lymphoid compartment in a patient with essential
                        thrombocythemia and B-chronic lymphocytic leukemia and in two relatives with lymphoproliferative
                        disorders
                     </span>
                     <span tagx="source">
                        <i>Acta Haematologica</i>
                     </span>
                     <span tagx="year">2009</span>
                     <span tagx="volume">122</span>
                     <div tagxxx="issue">1</div>
                     <span tagx="fpage">46</span>
                     <span tagx="lpage">49</span>
                     <span class="pub-id'">[10.1159/000243721]</span>
                     <span class="pub-id'">[2-s2.0-70349827133]</span>
                     <span class="pub-id'">[19816006]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B33"></a>
                  <label>33</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Swierczek</span>
                           <span tagx="given-names">S.</span>
                        </name>
                        <name>
                           <span tagx="surname">Nausova</span>
                           <span tagx="given-names">J.</span>
                        </name>
                        <name>
                           <span tagx="surname">Jelinek</span>
                           <span tagx="given-names">J.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Concomitant JAK2 V617F-positive polycythemia vera and B-cell chronic lymphocytic leukemia
                        in three patients originating from two separate hematopoietic stem cells
                     </span>
                     <span tagx="source">
                        <i>American Journal of Hematology</i>
                     </span>
                     <span tagx="year">2013</span>
                     <span tagx="volume">88</span>
                     <div tagxxx="issue">2</div>
                     <span tagx="fpage">157</span>
                     <span tagx="lpage">158</span>
                     <span class="pub-id'">[10.1002/ajh.23362]</span>
                     <span class="pub-id'">[2-s2.0-84872950600]</span>
                     <span class="pub-id'">[23280542]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B34"></a>
                  <label>34</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Salama</span>
                           <span tagx="given-names">M. E.</span>
                        </name>
                        <name>
                           <span tagx="surname">Swierczek</span>
                           <span tagx="given-names">S. I.</span>
                        </name>
                        <name>
                           <span tagx="surname">Tashi</span>
                           <span tagx="given-names">T.</span>
                        </name>
                        <name>
                           <span tagx="surname">Warby</span>
                           <span tagx="given-names">C. A.</span>
                        </name>
                        <name>
                           <span tagx="surname">Reading</span>
                           <span tagx="given-names">N. S.</span>
                        </name>
                        <name>
                           <span tagx="surname">Prchal</span>
                           <span tagx="given-names">J. T.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Calreticulin mutated prefibrotic-stage myelofibrosis and PMF represent an independent
                        clone from coexisting CLL
                     </span>
                     <span tagx="source">
                        <i>Blood</i>
                     </span>
                     <span tagx="year">2014</span>
                     <span tagx="volume">124</span>
                     <div tagxxx="issue">10</div>
                     <span tagx="fpage">1691</span>
                     <span tagx="lpage">1692</span>
                     <span class="pub-id'">[10.1182/blood-2014-04-568410]</span>
                     <span class="pub-id'">[2-s2.0-84907042864]</span>
                     <span class="pub-id'">[25190754]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B35"></a>
                  <label>35</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Nagai</span>
                           <span tagx="given-names">Y.</span>
                        </name>
                        <name>
                           <span tagx="surname">Kawahara</span>
                           <span tagx="given-names">M.</span>
                        </name>
                        <name>
                           <span tagx="surname">Sugino</span>
                           <span tagx="given-names">N.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">A case of minor BCR-ABL1 positive acute lymphoblastic leukemia following essential
                        thrombocythemia and originating from a clone distinct from that harboring the JAK2-V617F
                        mutation
                     </span>
                     <span tagx="source">
                        <i>Experimental Hematology &amp; Oncology</i>
                     </span>
                     <span tagx="year">2014</span>
                     <span tagx="volume">3</span>
                     <div tagxxx="issue">1, article 6</div>
                     <span class="pub-id'">[10.1186/2162-3619-3-6]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B36"></a>
                  <label>36</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Tao</span>
                           <span tagx="given-names">J.</span>
                        </name>
                        <name>
                           <span tagx="surname">Zhang</span>
                           <span tagx="given-names">X.</span>
                        </name>
                        <name>
                           <span tagx="surname">Lancet</span>
                           <span tagx="given-names">J.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Concurrence of B-lymphoblastic leukemia and myeloproliferative neoplasm with copy
                        neutral loss of heterozygosity at chromosome 1p harboring a MPL W515S mutation
                     </span>
                     <span tagx="source">
                        <i>Cancer Genetics</i>
                     </span>
                     <span tagx="year">2014</span>
                     <span tagx="volume">207</span>
                     <div tagxxx="issue">10–12</div>
                     <span tagx="fpage">489</span>
                     <span tagx="lpage">494</span>
                     <span class="pub-id'">[10.1016/j.cancergen.2014.10.001]</span>
                     <span class="pub-id'">[2-s2.0-84919679485]</span>
                     <span class="pub-id'">[25453399]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B37"></a>
                  <label>37</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Tefferi</span>
                           <span tagx="given-names">A.</span>
                        </name>
                        <name>
                           <span tagx="surname">Wassie</span>
                           <span tagx="given-names">E. A.</span>
                        </name>
                        <name>
                           <span tagx="surname">Guglielmelli</span>
                           <span tagx="given-names">P.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Type 1 versus Type 2 calreticulin mutations in essential thrombocythemia: a collaborative
                        study of 1027 patients
                     </span>
                     <span tagx="source">
                        <i>American Journal of Hematology</i>
                     </span>
                     <span tagx="year">2014</span>
                     <span tagx="volume">89</span>
                     <div tagxxx="issue">8</div>
                     <span tagx="fpage">E121</span>
                     <span tagx="lpage">E124</span>
                     <span class="pub-id'">[10.1002/ajh.23743]</span>
                     <span class="pub-id'">[2-s2.0-84904401956]</span>
                     <span class="pub-id'">[24753125]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B38"></a>
                  <label>38</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Cabagnols</span>
                           <span tagx="given-names">X.</span>
                        </name>
                        <name>
                           <span tagx="surname">Defour</span>
                           <span tagx="given-names">J. P.</span>
                        </name>
                        <name>
                           <span tagx="surname">Ugo</span>
                           <span tagx="given-names">V.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Differential association of calreticulin type 1 and type 2 mutations with myelofibrosis
                        and essential thrombocytemia: relevance for disease evolution
                     </span>
                     <span tagx="source">
                        <i>Leukemia</i>
                     </span>
                     <span tagx="year">2015</span>
                     <span tagx="volume">29</span>
                     <div tagxxx="issue">1</div>
                     <span tagx="fpage">249</span>
                     <span tagx="lpage">252</span>
                     <span class="pub-id'">[10.1038/leu.2014.270]</span>
                     <span class="pub-id'">[2-s2.0-84920596808]</span>
                     <span class="pub-id'">[25212275]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B39"></a>
                  <label>39</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Pietra</span>
                           <span tagx="given-names">D.</span>
                        </name>
                        <name>
                           <span tagx="surname">Rumi</span>
                           <span tagx="given-names">E.</span>
                        </name>
                        <name>
                           <span tagx="surname">Ferretti</span>
                           <span tagx="given-names">W.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative
                        neoplasms
                     </span>
                     <span tagx="source">
                        <i>Leukemia</i>
                     </span>
                     <span tagx="year">2015</span>
                     <span class="pub-id'">[10.1038/leu.2015.277]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B40"></a>
                  <label>40</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Vannucchi</span>
                           <span tagx="given-names">A. M.</span>
                        </name>
                        <name>
                           <span tagx="surname">Antonioli</span>
                           <span tagx="given-names">E.</span>
                        </name>
                        <name>
                           <span tagx="surname">Guglielmelli</span>
                           <span tagx="given-names">P.</span>
                        </name>
                        <name>
                           <span tagx="surname">Pardanani</span>
                           <span tagx="given-names">A.</span>
                        </name>
                        <name>
                           <span tagx="surname">Tefferi</span>
                           <span tagx="given-names">A.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Clinical correlates of JAK2V617F presence or allele burden in myeloproliferative neoplasms:
                        a critical reappraisal
                     </span>
                     <span tagx="source">
                        <i>Leukemia</i>
                     </span>
                     <span tagx="year">2008</span>
                     <span tagx="volume">22</span>
                     <div tagxxx="issue">7</div>
                     <span tagx="fpage">1299</span>
                     <span tagx="lpage">1307</span>
                     <span class="pub-id'">[10.1038/leu.2008.113]</span>
                     <span class="pub-id'">[2-s2.0-47649123488]</span>
                     <span class="pub-id'">[18496562]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B41"></a>
                  <label>41</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Barbui</span>
                           <span tagx="given-names">T.</span>
                        </name>
                     </span>
                     <span tagx="article-title">The leukemia controversy in myeloproliferative disorders: is it a natural progression
                        of the disease, a secondary sequel of therapy, or a combination of both?
                     </span>
                     <span tagx="source">
                        <i>Seminars in Hematology</i>
                     </span>
                     <span tagx="year">2004</span>
                     <span tagx="volume">41</span>
                     <div tagxxx="issue">2, supplement 2</div>
                     <span tagx="fpage">15</span>
                     <span tagx="lpage">17</span>
                     <span class="pub-id'">[15190518]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B42"></a>
                  <label>42</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Randi</span>
                           <span tagx="given-names">M. L.</span>
                        </name>
                        <name>
                           <span tagx="surname">Ruzzon</span>
                           <span tagx="given-names">E.</span>
                        </name>
                        <name>
                           <span tagx="surname">Luzzatto</span>
                           <span tagx="given-names">G.</span>
                        </name>
                        <name>
                           <span tagx="surname">Tezza</span>
                           <span tagx="given-names">F.</span>
                        </name>
                        <name>
                           <span tagx="surname">Girolami</span>
                           <span tagx="given-names">A.</span>
                        </name>
                        <name>
                           <span tagx="surname">Fabris</span>
                           <span tagx="given-names">F.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Safety profile of hydroxyurea in the treatment of patients with Philadelphia-negative
                        chronic myeloproliferative disorders
                     </span>
                     <span tagx="source">
                        <i>Haematologica</i>
                     </span>
                     <span tagx="year">2005</span>
                     <span tagx="volume">90</span>
                     <div tagxxx="issue">2</div>
                     <span tagx="fpage">261</span>
                     <span tagx="lpage">262</span>
                     <span class="pub-id'">[2-s2.0-14344263978]</span>
                     <span class="pub-id'">[15710584]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B43"></a>
                  <label>43</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Gangat</span>
                           <span tagx="given-names">N.</span>
                        </name>
                        <name>
                           <span tagx="surname">Wolanskyj</span>
                           <span tagx="given-names">A. P.</span>
                        </name>
                        <name>
                           <span tagx="surname">McClure</span>
                           <span tagx="given-names">R. F.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Risk stratification for survival and leukemic transformation in essential thrombocythemia:
                        a single institutional study of 605 patients
                     </span>
                     <span tagx="source">
                        <i>Leukemia</i>
                     </span>
                     <span tagx="year">2007</span>
                     <span tagx="volume">21</span>
                     <div tagxxx="issue">2</div>
                     <span tagx="fpage">270</span>
                     <span tagx="lpage">276</span>
                     <span class="pub-id'">[10.1038/sj.leu.2404500]</span>
                     <span class="pub-id'">[2-s2.0-33846540216]</span>
                     <span class="pub-id'">[17170720]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B44"></a>
                  <label>44</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Palandri</span>
                           <span tagx="given-names">F.</span>
                        </name>
                        <name>
                           <span tagx="surname">Catani</span>
                           <span tagx="given-names">L.</span>
                        </name>
                        <name>
                           <span tagx="surname">Testoni</span>
                           <span tagx="given-names">N.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Long-term follow-up of 386 consecutive patients with essential thrombocythemia: safety
                        of cytoreductive therapy
                     </span>
                     <span tagx="source">
                        <i>American Journal of Hematology</i>
                     </span>
                     <span tagx="year">2009</span>
                     <span tagx="volume">84</span>
                     <div tagxxx="issue">4</div>
                     <span tagx="fpage">215</span>
                     <span tagx="lpage">220</span>
                     <span class="pub-id'">[10.1002/ajh.21360]</span>
                     <span class="pub-id'">[2-s2.0-64549127701]</span>
                     <span class="pub-id'">[19208420]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B45"></a>
                  <label>45</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Björkholm</span>
                           <span tagx="given-names">M.</span>
                        </name>
                        <name>
                           <span tagx="surname">Derolf</span>
                           <span tagx="given-names">Å. R.</span>
                        </name>
                        <name>
                           <span tagx="surname">Hultcrantz</span>
                           <span tagx="given-names">M.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Treatment-related risk factors for transformation to acute myeloid leukemia and myelodysplastic
                        syndromes in myeloproliferative neoplasms
                     </span>
                     <span tagx="source">
                        <i>Journal of Clinical Oncology</i>
                     </span>
                     <span tagx="year">2011</span>
                     <span tagx="volume">29</span>
                     <div tagxxx="issue">17</div>
                     <span tagx="fpage">2410</span>
                     <span tagx="lpage">2415</span>
                     <span class="pub-id'">[10.1200/JCO.2011.34.7542]</span>
                     <span class="pub-id'">[2-s2.0-79959203501]</span>
                     <span class="pub-id'">[21537037]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B46"></a>
                  <label>46</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Pettersson</span>
                           <span tagx="given-names">H.</span>
                        </name>
                        <name>
                           <span tagx="surname">Knutsen</span>
                           <span tagx="given-names">H.</span>
                        </name>
                        <name>
                           <span tagx="surname">Holmberg</span>
                           <span tagx="given-names">E.</span>
                        </name>
                        <name>
                           <span tagx="surname">Andréasson</span>
                           <span tagx="given-names">B.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Increased incidence of another cancer in myeloproliferative neoplasms patients at
                        the time of diagnosis
                     </span>
                     <span tagx="source">
                        <i>European Journal of Haematology</i>
                     </span>
                     <span tagx="year">2015</span>
                     <span tagx="volume">94</span>
                     <div tagxxx="issue">2</div>
                     <span tagx="fpage">152</span>
                     <span tagx="lpage">156</span>
                     <span class="pub-id'">[10.1111/ejh.12410]</span>
                     <span class="pub-id'">[2-s2.0-84923058248]</span>
                     <span class="pub-id'">[25039361]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B47"></a>
                  <label>47</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Krahling</span>
                           <span tagx="given-names">T.</span>
                        </name>
                        <name>
                           <span tagx="surname">Balassa</span>
                           <span tagx="given-names">K.</span>
                        </name>
                        <name>
                           <span tagx="surname">Kiss</span>
                           <span tagx="given-names">K. P.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Co-occurrence of myeloproliferative neoplasms and solid tumors is attributed to a
                        synergism between cytoreductive therapy and the common TERT polymorphism rs2736100
                     </span>
                     <span tagx="source">
                        <i>Cancer Epidemiology Biomarkers &amp; Prevention</i>
                     </span>
                     <span tagx="year">2016</span>
                     <span tagx="volume">25</span>
                     <div tagxxx="issue">1</div>
                     <span tagx="fpage">98</span>
                     <span tagx="lpage">104</span>
                     <span class="pub-id'">[10.1158/1055-9965.epi-15-0805]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B48"></a>
                  <label>48</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Hermouet</span>
                           <span tagx="given-names">S.</span>
                        </name>
                        <name>
                           <span tagx="surname">Bigot-Corbel</span>
                           <span tagx="given-names">E.</span>
                        </name>
                        <name>
                           <span tagx="surname">Gardie</span>
                           <span tagx="given-names">B.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Pathogenesis of myeloproliferative neoplasms: role and mechanisms of chronic inflammation</span>
                     <span tagx="source">
                        <i>Mediators of Inflammation</i>
                     </span>
                     <span tagx="year">2015</span>
                     <span tagx="volume">2015</span>
                     <span tagx="fpage">16</span>
                     <span class="pub-id'">[145293]</span>
                     <span class="pub-id'">[10.1155/2015/145293]</span>
                  </span>
               </li>
            </ul>
         </div>
      </back>
      <div tagxxx="floats-group">
         <fig>
            <label>Figure 1</label>
            <caption>
               <p>(a) Bone marrow trephine biopsy at diagnosis of essential thrombocythemia (Hematoxylin
                  and Eosin; magnification ×20); (b) fragment length detection of the
                  <i> CALR</i> mutation; (c) bone marrow aspirate at diagnosis of acute lymphoblastic leukemia;
                  (d) bone marrow trephine biopsy following two courses of chemotherapy (Hematoxylin
                  and Eosin; magnification ×20); (e) mutant
                  <i> CALR</i> allele burdens.
               </p>
            </caption>
            <graphic></graphic>
         </fig>
      </div>
   </article>
</html>